Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
Neurocrine (NBIX) Financial Statements
1,237 Followers
Neurocrine Financial Overview
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 515.30M | $ 515.20M | $ 498.80M | $ 452.70M | $ 420.40M |
| Gross Profit | $ 507.80M | $ 506.70M | $ 487.60M | $ 441.20M | $ 411.90M |
| EBIT | $ 35.60M | $ 199.30M | $ 116.70M | $ 122.90M | $ -102.20M |
| EBITDA | $ 41.80M | $ 205.00M | $ 122.40M | $ 128.20M | $ -97.00M |
| Net Income Common Stockholders | $ 43.40M | $ 147.70M | $ 83.10M | $ 95.50M | $ -76.60M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 1.21B | $ 1.03B | $ 1.10B | $ 976.70M | $ 894.60M |
| Total Assets | $ 3.47B | $ 3.25B | $ 2.85B | $ 2.61B | $ 2.36B |
| Total Debt | $ 375.70M | $ 428.40M | $ 255.80M | $ 258.80M | $ 259.90M |
| Net Debt | $ -834.90M | $ -603.20M | $ -839.30M | $ -717.90M | $ -634.70M |
| Total Liabilities | $ 1.09B | $ 1.02B | $ 846.10M | $ 760.10M | $ 675.30M |
| Stockholders Equity | $ 2.39B | $ 2.23B | $ 2.00B | $ 1.85B | $ 1.68B |
| Cash Flow | - | ||||
| Free Cash Flow | $ 119.10M | $ 118.10M | $ 204.40M | $ 172.80M | $ -133.70M |
| Operating Cash Flow | $ 130.30M | $ 123.50M | $ 212.00M | $ 179.60M | $ -125.20M |
| Investing Cash Flow | $ -55.00M | $ -201.80M | $ -97.30M | $ -125.90M | $ -42.10M |
| Financing Cash Flow | $ 69.90M | $ 35.40M | $ 18.80M | $ 2.90M | $ 8.20M |